Antibiotic Coating of the Artificial Urinary Sphincter (AMS 800): Is it Worthwhile?

[1]  J. Sandhu,et al.  Evaluation and Management of Postprostatectomy Incontinence: A Systematic Review of Current Literature. , 2016, European urology focus.

[2]  R. Seiler,et al.  Complications and Short-Term Explantation Rate Following Artificial Urinary Sphincter Implantation: Results from a Large Middle European Multi-Institutional Case Series , 2016, Urologia Internationalis.

[3]  R. Bauer,et al.  Efficacy and safety of the ZSI375 artificial urinary sphincter for male stress urinary incontinence: lessons learned , 2016, World Journal of Urology.

[4]  B. Linder,et al.  Long-term Outcomes Following Artificial Urinary Sphincter Placement: An Analysis of 1082 Cases at Mayo Clinic. , 2015, Urology.

[5]  L. Rangel,et al.  Perioperative Complications following Artificial Urinary Sphincter Placement. , 2015, The Journal of urology.

[6]  P. Mozer,et al.  Long‐term functional outcomes after artificial urinary sphincter implantation in men with stress urinary incontinence , 2015, BJU international.

[7]  J. Sandhu.  Management of complications and residual symptoms in men with an artificial urinary sphincter. , 2014, The Journal of urology.

[8]  K. McCammon,et al.  Artificial urinary sphincter for post‐prostatectomy incontinence: A review , 2014, International journal of urology : official journal of the Japanese Urological Association.

[9]  N. Sathianathen,et al.  Outcomes of artificial urinary sphincter implantation in the irradiated patient , 2014, BJU international.

[10]  B. Linder,et al.  Long-term device outcomes of artificial urinary sphincter reimplantation following prior explantation for erosion or infection. , 2014, The Journal of urology.

[11]  D. Elliott,et al.  The impact of an antibiotic coating on the artificial urinary sphincter infection rate. , 2013, The Journal of urology.

[12]  M. Drake,et al.  The artificial urinary sphincter after a quarter of a century: a critical systematic review of its use in male non-neurogenic incontinence. , 2013, European urology.

[13]  S. Mandava,et al.  Infection retardant coated inflatable penile prostheses decrease the incidence of infection: a systematic review and meta-analysis. , 2012, The Journal of urology.

[14]  D. Flum,et al.  Importance of Perioperative Glycemic Control in General Surgery: A Report From the Surgical Care and Outcomes Assessment Program , 2012, Annals of surgery.

[15]  Christian Melander,et al.  Controlling Bacterial Biofilms , 2009, Chembiochem : a European journal of chemical biology.

[16]  James S. Magera,et al.  Artificial urinary sphincter infection: causative organisms in a contemporary series. , 2008, The Journal of urology.

[17]  Simon P. Kim,et al.  Long-term durability and functional outcomes among patients with artificial urinary sphincters: a 10-year retrospective review from the University of Michigan. , 2008, The Journal of urology.

[18]  E. B. Butler,et al.  13 years of experience with artificial urinary sphincter implantation at Baylor College of Medicine. , 2007, The Journal of urology.

[19]  W. Zimmerli,et al.  Prosthetic joint infections: update in diagnosis and treatment. , 2005, Swiss medical weekly.

[20]  C. Carson.  Efficacy of antibiotic impregnation of inflatable penile prostheses in decreasing infection in original implants. , 2004, The Journal of urology.

[21]  Robin Patel,et al.  Molecular and antibiofilm approaches to prosthetic joint infection. , 2003, Clinical orthopaedics and related research.

[22]  A. Stone,et al.  Artificial urinary sphincter implantation in the irradiated patient: safety, efficacy and satisfaction , 2002, BJU international.

[23]  R. Darouiche.  Device-associated infections: a macroproblem that starts with microadherence. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[24]  L. Sampath,et al.  In Vitro and In Vivo Efficacy of Catheters Impregnated With Antiseptics or Antibiotics: Evaluation of the Risk of Bacterial Resistance to the Antimicrobials in the Catheters , 2001, Infection Control & Hospital Epidemiology.

[25]  S. Tambe,et al.  In vitro evaluation of the risk of developing bacterial resistance to antiseptics and antibiotics used in medical devices. , 2001, The Journal of antimicrobial chemotherapy.

[26]  A. Mundy,et al.  The long-term outcome of artificial urinary sphincters. , 2000, The Journal of urology.

[27]  P. Scardino,et al.  Efficacy of antimicrobial-impregnated bladder catheters in reducing catheter-associated bacteriuria: a prospective, randomized, multicenter clinical trial. , 1999, Urology.

[28]  J. Costerton,et al.  Bacterial biofilms: a common cause of persistent infections. , 1999, Science.

[29]  O. Wenker,et al.  A comparison of two antimicrobial-impregnated central venous catheters. Catheter Study Group. , 1999, The New England journal of medicine.

[30]  C. Hajivassiliou.  A Review of the Complications and Results of Implantation of the AMS Artificial Urinary Sphincter , 1999, European Urology.

[31]  G. Bodey,et al.  The broad-spectrum activity and efficacy of catheters coated with minocycline and rifampin. , 1996, The Journal of infectious diseases.

[32]  S. Boyd,et al.  Post-operative risk factors associated with artificial urinary sphincter infection-erosion. , 1995, British journal of urology.

[33]  N. Singla,et al.  Review of single-surgeon 10-year experience with artificial urinary sphincter with report of sterile cuff erosion managed nonsurgically. , 2015, Urology.

[34]  C. Stief,et al.  Risk factors for artificial urinary sphincter failure , 2015, World Journal of Urology.